Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Dabei Tang"'
Autor:
Yanfang Zhao, Wenjia Su, Guohua Liang, Xiaoyu Shan, Weiwei Ma, Dabei Tang, Liru Li, Xingjian Niu, Shu Zhao, Qingyuan Zhang, Wenhui Zhao
Publikováno v:
BMC Pharmacology and Toxicology, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Purpose In clinical practice, the risk factors for pegylated liposomal doxorubicin-related hand-foot syndrome remain unclear. The purpose of this study was to determine the risk factors associated with hand-foot syndrome in patients with lym
Externí odkaz:
https://doaj.org/article/a27bb91a87f14d35b2ec057ea0420eab
Autor:
Guohua Liang, Wenjie Ma, Yanfang Zhao, Eryu Liu, Xiaoyu Shan, Weiwei Ma, Dabei Tang, Liru Li, Xingjian Niu, Wenhui Zhao, Qingyuan Zhang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Hand-foot syndrome (HFS) is a side effect of skin related to pegylated liposomal doxorubicin (PLD) application. Moderate to severe hand-foot syndrome (MSHFS) might have a serious impact on patients’ quality of life and treatment
Externí odkaz:
https://doaj.org/article/5dc0a084771d49f09c301162e907d64b
Publikováno v:
Iranian Journal of Public Health, Vol 49, Iss 5 (2020)
Background: To explore IFN-γ (interferon-γ) and IL-4 (interleukin-4) expressions before and after the treatment of LN (lupus nephritis) and their values for efficacy prediction and evaluation. Methods: Altogether 107 patients with LN treated in
Externí odkaz:
https://doaj.org/article/8b0b34fb86674dc2a31733c5aebfd124
Autor:
Jingxuan Wang, Kangping Lu, Ying Song, Shu Zhao, Wenjie Ma, Qijia Xuan, Dabei Tang, Hong Zhao, Lei Liu, Qingyuan Zhang
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133964 (2015)
Breast cancer patients treated with aromatase inhibitors (AIs) may experience musculoskeletal adverse events (MS-AEs). Several studies have confirmed that the RANKL/RANK/OPG signaling pathway plays a dominant role in bone health. Therefore, this stud
Externí odkaz:
https://doaj.org/article/69148a7cf14849c69117ad43041d6492
Autor:
Jingxuan Wang, Kangping Lu, Ying Song, Li Xie, Shu Zhao, Yunxuan Wang, Wenzhou Sun, Lei Liu, Hong Zhao, Dabei Tang, Wenjie Ma, Bo Pan, Qijia Xuan, Hang Liu, Qingyuan Zhang
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68798 (2013)
Women with breast cancer treated with aromatase inhibitors (AIs) may experience musculoskeletal symptoms that lead to discontinuation of effective therapy. The purpose of the current study is to evaluate the clinical and genetic predictors for AIs-re
Externí odkaz:
https://doaj.org/article/8a3f63b17f3a469babc882c623d3f649
Publikováno v:
Life sciences. 306
lncRNA ANRIL expression is dysregulated in many human cancers and is thus a useful prognostic marker for cancer patients. However, whether ANRIL is involved in drug resistance in triple-negative breast cancer (TNBC) has not yet been investigated.A lu
Background Ribosomal protein 32 (RPL32) plays an important role in carcinogenesis. Previous studies have shown that RPL32 is closely related to the occurrence and development of tumor tissues. Nevertheless, the clinicopathological features and functi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6bc3d972da4ddd7bcdb83374a662f781
https://doi.org/10.21203/rs.3.rs-1539834/v1
https://doi.org/10.21203/rs.3.rs-1539834/v1
Publikováno v:
Brain Tumor Pathology. 38:50-58
Patients with primary central nervous system lymphoma (PCNSL) have a prognosis poorer than that of systemic lymphoma patients. In patients with this condition, TLR4/STAT3 pathway alterations and the MYD88 L265P mutation may be viable targets for ther
BackgroundBreast cancer is the main cause of death among women worldwide. More and more long non-coding RNAs (lncRNAs) have been identified as oncogenes or tumor suppressors during cancer development. However, whether ANRIL is involved in drug resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4102069fa19e1bd683f573ae90479655
https://doi.org/10.21203/rs.3.rs-1062354/v1
https://doi.org/10.21203/rs.3.rs-1062354/v1
Autor:
Liru Li, Wenjia Su, Shu Zhao, Xingjian Niu, Dabei Tang, Qingyuan Zhang, Wenhui Zhao, Xiaoyu Shan, Weiwei Ma, Yanfang Zhao, Guohua Liang
Publikováno v:
BMC Pharmacology and Toxicology, Vol 22, Iss 1, Pp 1-8 (2021)
BMC Pharmacology & Toxicology
BMC Pharmacology & Toxicology
Purpose In clinical practice, the risk factors for pegylated liposomal doxorubicin-related hand-foot syndrome remain unclear. The purpose of this study was to determine the risk factors associated with hand-foot syndrome in patients with lymphoma usi